A股異動 | 華大智造(688114.SH)漲約9% 市值超460億元
格隆匯9月27日丨次新股華大智造(688114.SH)大幅拉昇漲約9%,現報111.6元,總市值超460億元。昨日晚公司發佈多項股票期權激勵相關公吿,138.186萬份股票期權擬行權。截至公吿日,公司合計向符合行權條件的94名激勵對象授予414.56萬份股票期權。值得一提的是,根據公司《期權激勵方案》的規定,激勵對象行權所獲股票自行權日起3年內不得減持,體現出公司對自身長期可持續發展的堅定信心,用實際行動維護廣大投資者的利益。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.